Cph Group Ag Class A · SIX:CPHN
Cph Group Ag Class A — Investor Day (September 2018)
26 slides from Cph Group Ag Class A's investor day presentation, Sep 13, 2018
Slide 1: Investor Day 13 September 2018
Investor Day 13 September 2018 Wolfgang Grimm CEO
Slide 2: Agenda
Agenda Perlen Packaging The global pharmaceutical market Primary packaging: solid-form and powder Product innovations 2
Slide 3: Agenda
Agenda Perlen Packaging The global pharmaceutical market Primary packaging: solid-form and powder Product innovations 3
Slide 4: The CPH Group's Packaging Division
The CPH Group’s Packaging Division Europe North America Asia South America Perlen Packaging Ltda., Anápolis Perlen Packaging LLC, Whippany Perlen Packaging GmbH, Müllheim Perlen Converting AG, Perlen Perlen Packaging (Suzhou) Co., Ltd. Service and logistics centre Service and logistics centre Centre
Slide 5: Agenda
Agenda Perlen Packaging The global pharmaceutical market Primary packaging: solid-form and powder Product innovations 5
Slide 6: Megatrends in pharmaceuticals
Megatrends in pharmaceuticals • Growth and ageing of the world’s population • Urbanization • Lifestyle illnesses Better medical treatments Senior-friendly packagings Personalized packagings Growth in the +60 age group Source: UN Population Division 6
Slide 7: Top 20 pharma therapy categories
Top 20 pharma therapy categories Source: EvaluatePharma® August 2016 7
Slide 8: Pharma market rankings
Pharma market rankings The top 20 countries 2008 RANK 2013 RANK 2019 RANK 1 United States 1 United States 1 United States 2 Japan 2 China 2 China 3 China 3 Japan 3 Japan 4 France 4 Germany 4 Brazil 5 Germany 5 France 5 Germany 6 Italy 6 France 6 Brazil 7 Italy 7 Spain 7 Italy 8 UK 8 Canada 8 UK 9 Ca
Slide 9: 2014-2019 pharma market growth in USD billion
2014-2019 pharma market growth in USD billion 279 215 322 243 Pharmerging Markets 500 CAGR 10-12% 406 Europe CAGR 1-4% USA CAGR 3-6% 88 91 Japan CAGR -1-2% 76 103 302 202 Latin America CAGR 5-8% Asia, Africa, Australia CAGR 7-10% 2014 2019 Source: IMS Health, Pharma Prognosis May 2015, SAP PP “Pharm
Slide 10: Our competencies
® perlen Our competencies OW packaging barrier films | »
Slide 11: Our references (in alphabetical order)
Our references (in alphabetical order) 11
Slide 12: Our competencies
)) perlen Our competencies packaging 12
Slide 13: Centre of excellence for barrier films
Centre of excellence for barrier films Perlen Packaging (Suzhou) Co., Ltd. / China • Multiple in-line coating stations Greenfield investment in China State-of-the-art machine technology • Camera system Visual surface checks Maximum safety • GMP Latest GMP guidelines Cleanroom Class 8 13
Slide 14: Agenda
Agenda Perlen Packaging The global pharmaceutical market Primary packaging: solid-form and powder Product innovations 14
Slide 15: 100% focus on pharmaceuticals products
100% focus on pharmaceuticals products 90% primary pharma packagings (solid-dosage forms, blister) 10% special applications (ampoule packagings, syringe packagings, medical devices) 15
Slide 16: Packaging markets
Packaging markets Monofilms Barrier films Liquid films Anti-counterfeiting films Antimicrobial films Ampoule/syringe packaging films
Slide 17: The PERLALUX product structure
The PERLALUX® product structure Three generations of blister packs PVC / PVdC PVC / PE / PVdC PVC / PE / PVdC / PE / PVC 1970-1990 1983-2009 2009-today 17
Slide 18: Innovations launched
Innovations launched PERLAMED™ BLISTair development project PERLATOP™ 2017 development project 2015 Ultra Protect Antimicrobial coating 2012 2010 MultiLayer Tristar Ultra 180 2010 2009 Tristar Ultra 120 Identity 2007 2005 Generex Starflex 2002 1997 Duplex Tristar 1970 1983 18
Slide 19: Agenda
Agenda Perlen Packaging The global pharmaceutical market Primary packaging: solid-form and powder Product innovations 19
Slide 20: Our competencies
)) perlen Our competencies packaging 20
Slide 21: Innovations in the pharma product range
Innovations in the pharma product range solid powder Extension of Inhalers product range Solid-dose packagings Complementary combination of product/market PVC / PE / PVdC / PE / PVC 2009-today Strengthening and extension of existing product segment liquid Liquid 21
Slide 22: PERLAZID - antiseptic
PERLAZID® - antiseptic • Antiseptic films, labels, coatings and sprays • Dermatologically tested • Ecofriendly • 100x proven effectiveness Added value: • Reduces germs by over 99.9% (> 3 log) • Bacteria and fungus fully eliminated • Germs cannot develop resistance • Critical surfaces protected and s
Slide 23: BLISTair - our new product innovation
BLISTair - our new product innovation 23
Slide 24: PERLAMED - BLISTair
PERLAMED™ - BLISTair PERLAMED™ - BLISTair: • Thermoformed single-use inhaler • The primary packaging is also the device • Differing film types = differing barrier properties Added value: • A clean and hygienic new device for every inhalation • Modifiable at any time • No injection moulding and no co
Slide 25: Awards earned by PERLAMED - BLISTair in 2017/18
Awards earned by PERLAMED™- BLISTair in 2017/18 2017 Deutscher Verpackungspreis 2017 CPhI Pharma Award 2017 IHZ-Innovationspreis 2018 Alufoil Trophy 2018 Swiss Packaging Award 2018 World Star 25
Slide 26: Thank you for your attention!
Thank you for your attention! Perlen Packaging